Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03257761
Title Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Southern California
Indications

hepatocellular carcinoma

pancreatic cancer

cholangiocarcinoma

Therapies

Durvalumab + Guadecitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.